News
The global sales of the phlebotomy equipment market are estimated to be worth USD 14.69 billion in 2025 and are anticipated ...
NORTH LIBERTY, Iowa (KCRG) - A Tiffin man is facing several charges for allegedly stealing and attempting to sell $60,000 worth of medical and construction equipment from the new University of ...
Rusfertide significantly reduced phlebotomy needs in PV patients, with 76.9% achieving clinical response versus 32.9% in the placebo group. The therapy maintained hematocrit levels below 45% in 62 ...
Rusfertide more than doubled the percentage of patients achieving a clinical response, defined as the absence of phlebotomy eligibility during study weeks 20-32 of the trial (76.9% vs 32.9% with ...
In the study, patients dependent on frequent phlebotomy, with or without treatment with cytoreductive therapy, were randomized to receive once-weekly rusfertide or placebo, as an add-on to current ...
Rusfertide plus current standard of care more than doubled clinical response rates across high- and low-risk PV groups, significantly reducing phlebotomy eligibility compared to placebo plus ...
Forty phlebotomists at Gloucestershire Hospitals NHS Foundation Trust have been striking for over 60 days to demand re-banding. Phlebotomists are specialist health workers who take and handle patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results